+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Analgesics in Australia

  • ID: 228392
  • Report
  • Region: Australasia, Australia
  • 21 Pages
  • Euromonitor International
1 of 2
Increasing concerns in Australia about the addictive nature of codeine resulted in the rescheduling of all codeine-containing OTC medicines to prescription-only status in February 2018. This ban on OTC sales of codeine had a significant impact on sales of analgesics during 2018, particularly on combination medicines.

The Analgesics in Australia report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2014-2018, allowing you to identify the sectors driving growth. Forecasts to 2023 illustrate how the market is set to change.

Product coverage: Systemic Analgesics, Topical Analgesics/Anaesthetic.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
  • Get a detailed picture of the Analgesics market;
  • Pinpoint growth sectors and identify factors driving change;
  • Understand the competitive environment, the market’s major players and leading brands;
  • Use five-year forecasts to assess how the market is predicted to develop.
Note: Product cover images may vary from those shown
2 of 2
ANALGESICS IN AUSTRALIA

List of Contents and Tables
Headlines
Prospects
Reverse Switch Has A Negative Impact on Sales of Analgesics
Alternative Analgesics for Mild Pain Likely To Fill the Gap Left by Codeine's Withdrawal
Ageing Population Set To Spur Growth in Analgesics
Competitive Landscape
Gsk Consumer Healthcare Continues To Lead in Analgesics
Companies Respond To the Ban on OTC Sales of Codeine
Panadol Bounces Back Despite Strong Competition From Generics
Category Data
Table 1 Sales of Analgesics by Category: Value 2013-2018
Table 2 Sales of Analgesics by Category: % Value Growth 2013-2018
Table 3 Sales of Topical Analgesics/Anaesthetic by Format: % Value 2013-2018
Table 4 NBO Company Shares of Analgesics: % Value 2014-2018
Table 5 LBN Brand Shares of Analgesics: % Value 2015-2018
Table 6 Forecast Sales of Analgesics by Category: Value 2018-2023
Table 7 Forecast Sales of Analgesics by Category: % Value Growth 2018-2023
Executive Summary
Regulation and Shifting Demand for Vitamins and Dietary Supplement Define Industry
Consumer Health Products Remain Popular in Australia But Sales Slow Down
Acquisitions of Local Companies Continue
Distribution Continues To Evolve As the Presence of Discount Pharmacies Increases
the Trend Towards Self-care Management Set To Support Consumer Health Sales
Market Indicators
Table 8 Consumer Expenditure on Health Goods and Medical Services: Value 2013-2018
Table 9 Life Expectancy at Birth 2013-2018
Market Data
Table 10 Sales of Consumer Health by Category: Value 2013-2018
Table 11 Sales of Consumer Health by Category: % Value Growth 2013-2018
Table 12 NBO Company Shares of Consumer Health: % Value 2014-2018
Table 13 LBN Brand Shares of Consumer Health: % Value 2015-2018
Table 14 Penetration of Private Label in Consumer Health by Category: % Value 2013-2018
Table 15 Distribution of Consumer Health by Format: % Value 2013-2018
Table 16 Distribution of Consumer Health by Format and Category: % Value 2018
Table 17 Forecast Sales of Consumer Health by Category: Value 2018-2023
Table 18 Forecast Sales of Consumer Health by Category: % Value Growth 2018-2023
Appendix
OTC Registration and Classification
Vitamins and Dietary Supplements Registration and Classification
Self-medication/self-care and Preventive Medicine
Switches
Summary 1 OTC: Switches
Definitions
Sources
Summary 2 Research Sources
Note: Product cover images may vary from those shown
3 of 2

Loading
LOADING...

Adroll
adroll